Global Pet Antibiotic Market Growth 2022-2028
The global market for Pet Antibiotic is estimated to increase from US$ million in 2021 to reach US$ million by 2028, exhibiting a CAGR of % during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
The APAC Pet Antibiotic market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The United States Pet Antibiotic market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The Europe Pet Antibiotic market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The China Pet Antibiotic market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
Global key Pet Antibiotic players cover Elanco, Zoetis, Merck Animal Health, Merial and Bayer HealthCare, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
Report Coverage
This latest report provides a deep insight into the global Pet Antibiotic market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.
This report aims to provide a comprehensive picture of the global Pet Antibiotic market, with both quantitative and qualitative data, to help readers understand how the Pet Antibiotic market scenario changed across the globe during the pandemic and Russia-Ukraine War.
The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions and volume in K Units.
Market Segmentation:
The study segments the Pet Antibiotic market and forecasts the market size by Type (Oral, Injection and Others), by Application (Dogs, Cats and Others,), and region (APAC, Americas, Europe, and Middle East & Africa).
Segmentation by type
Oral
Injection
Others
Segmentation by application
Dogs
Cats
Others
Segmentation by region
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
Major companies covered
Elanco
Zoetis
Merck Animal Health
Merial
Bayer HealthCare
Boehringer Ingelheim GmbH
Ceva Santé Animale
Virbac Group
HealthforAnimals
Cymedica
Dechra
Jinhe Biotechnology
Orion Corporation
Phibro Animal Health Corporation
Vetoquinol
Virbac
Zydus
Chapter Introduction
Chapter 1: Scope of Pet Antibiotic, Research Methodology, etc.
Chapter 2: Executive Summary, global Pet Antibiotic market size (sales and revenue) and CAGR, Pet Antibiotic market size by region, by type, by application, historical data from 2017 to 2022, and forecast to 2028.
Chapter 3: Pet Antibiotic sales, revenue, average price, global market share, and industry ranking by company, 2017-2022
Chapter 4: Global Pet Antibiotic sales and revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, sales segment by country, by type, and type.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global Pet Antibiotic market size forecast by region, by country, by type, and application.
Chapter 13: Comprehensive company profiles of the leading players, including Elanco, Zoetis, Merck Animal Health, Merial, Bayer HealthCare, Boehringer Ingelheim GmbH, Ceva Santé Animale, Virbac Group and HealthforAnimals, etc.
Chapter 14: Research Findings and Conclusion
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Pet Antibiotic Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Pet Antibiotic by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Pet Antibiotic by Country/Region, 2017, 2022 & 2028
2.2 Pet Antibiotic Segment by Type
2.2.1 Oral
2.2.2 Injection
2.2.3 Others
2.3 Pet Antibiotic Sales by Type
2.3.1 Global Pet Antibiotic Sales Market Share by Type (2017-2022)
2.3.2 Global Pet Antibiotic Revenue and Market Share by Type (2017-2022)
2.3.3 Global Pet Antibiotic Sale Price by Type (2017-2022)
2.4 Pet Antibiotic Segment by Application
2.4.1 Dogs
2.4.2 Cats
2.4.3 Others
2.5 Pet Antibiotic Sales by Application
2.5.1 Global Pet Antibiotic Sale Market Share by Application (2017-2022)
2.5.2 Global Pet Antibiotic Revenue and Market Share by Application (2017-2022)
2.5.3 Global Pet Antibiotic Sale Price by Application (2017-2022)
3 Global Pet Antibiotic by Company
3.1 Global Pet Antibiotic Breakdown Data by Company
3.1.1 Global Pet Antibiotic Annual Sales by Company (2020-2022)
3.1.2 Global Pet Antibiotic Sales Market Share by Company (2020-2022)
3.2 Global Pet Antibiotic Annual Revenue by Company (2020-2022)
3.2.1 Global Pet Antibiotic Revenue by Company (2020-2022)
3.2.2 Global Pet Antibiotic Revenue Market Share by Company (2020-2022)
3.3 Global Pet Antibiotic Sale Price by Company
3.4 Key Manufacturers Pet Antibiotic Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Pet Antibiotic Product Location Distribution
3.4.2 Players Pet Antibiotic Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Pet Antibiotic by Geographic Region
4.1 World Historic Pet Antibiotic Market Size by Geographic Region (2017-2022)
4.1.1 Global Pet Antibiotic Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Pet Antibiotic Annual Revenue by Geographic Region
4.2 World Historic Pet Antibiotic Market Size by Country/Region (2017-2022)
4.2.1 Global Pet Antibiotic Annual Sales by Country/Region (2017-2022)
4.2.2 Global Pet Antibiotic Annual Revenue by Country/Region
4.3 Americas Pet Antibiotic Sales Growth
4.4 APAC Pet Antibiotic Sales Growth
4.5 Europe Pet Antibiotic Sales Growth
4.6 Middle East & Africa Pet Antibiotic Sales Growth
5 Americas
5.1 Americas Pet Antibiotic Sales by Country
5.1.1 Americas Pet Antibiotic Sales by Country (2017-2022)
5.1.2 Americas Pet Antibiotic Revenue by Country (2017-2022)
5.2 Americas Pet Antibiotic Sales by Type
5.3 Americas Pet Antibiotic Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Pet Antibiotic Sales by Region
6.1.1 APAC Pet Antibiotic Sales by Region (2017-2022)
6.1.2 APAC Pet Antibiotic Revenue by Region (2017-2022)
6.2 APAC Pet Antibiotic Sales by Type
6.3 APAC Pet Antibiotic Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Pet Antibiotic by Country
7.1.1 Europe Pet Antibiotic Sales by Country (2017-2022)
7.1.2 Europe Pet Antibiotic Revenue by Country (2017-2022)
7.2 Europe Pet Antibiotic Sales by Type
7.3 Europe Pet Antibiotic Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Pet Antibiotic by Country
8.1.1 Middle East & Africa Pet Antibiotic Sales by Country (2017-2022)
8.1.2 Middle East & Africa Pet Antibiotic Revenue by Country (2017-2022)
8.2 Middle East & Africa Pet Antibiotic Sales by Type
8.3 Middle East & Africa Pet Antibiotic Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Pet Antibiotic
10.3 Manufacturing Process Analysis of Pet Antibiotic
10.4 Industry Chain Structure of Pet Antibiotic
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Pet Antibiotic Distributors
11.3 Pet Antibiotic Customer
12 World Forecast Review for Pet Antibiotic by Geographic Region
12.1 Global Pet Antibiotic Market Size Forecast by Region
12.1.1 Global Pet Antibiotic Forecast by Region (2023-2028)
12.1.2 Global Pet Antibiotic Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Pet Antibiotic Forecast by Type
12.7 Global Pet Antibiotic Forecast by Application
13 Key Players Analysis
13.1 Elanco
13.1.1 Elanco Company Information
13.1.2 Elanco Pet Antibiotic Product Offered
13.1.3 Elanco Pet Antibiotic Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Elanco Main Business Overview
13.1.5 Elanco Latest Developments
13.2 Zoetis
13.2.1 Zoetis Company Information
13.2.2 Zoetis Pet Antibiotic Product Offered
13.2.3 Zoetis Pet Antibiotic Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Zoetis Main Business Overview
13.2.5 Zoetis Latest Developments
13.3 Merck Animal Health
13.3.1 Merck Animal Health Company Information
13.3.2 Merck Animal Health Pet Antibiotic Product Offered
13.3.3 Merck Animal Health Pet Antibiotic Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Merck Animal Health Main Business Overview
13.3.5 Merck Animal Health Latest Developments
13.4 Merial
13.4.1 Merial Company Information
13.4.2 Merial Pet Antibiotic Product Offered
13.4.3 Merial Pet Antibiotic Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Merial Main Business Overview
13.4.5 Merial Latest Developments
13.5 Bayer HealthCare
13.5.1 Bayer HealthCare Company Information
13.5.2 Bayer HealthCare Pet Antibiotic Product Offered
13.5.3 Bayer HealthCare Pet Antibiotic Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Bayer HealthCare Main Business Overview
13.5.5 Bayer HealthCare Latest Developments
13.6 Boehringer Ingelheim GmbH
13.6.1 Boehringer Ingelheim GmbH Company Information
13.6.2 Boehringer Ingelheim GmbH Pet Antibiotic Product Offered
13.6.3 Boehringer Ingelheim GmbH Pet Antibiotic Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Boehringer Ingelheim GmbH Main Business Overview
13.6.5 Boehringer Ingelheim GmbH Latest Developments
13.7 Ceva Santé Animale
13.7.1 Ceva Santé Animale Company Information
13.7.2 Ceva Santé Animale Pet Antibiotic Product Offered
13.7.3 Ceva Santé Animale Pet Antibiotic Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Ceva Santé Animale Main Business Overview
13.7.5 Ceva Santé Animale Latest Developments
13.8 Virbac Group
13.8.1 Virbac Group Company Information
13.8.2 Virbac Group Pet Antibiotic Product Offered
13.8.3 Virbac Group Pet Antibiotic Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Virbac Group Main Business Overview
13.8.5 Virbac Group Latest Developments
13.9 HealthforAnimals
13.9.1 HealthforAnimals Company Information
13.9.2 HealthforAnimals Pet Antibiotic Product Offered
13.9.3 HealthforAnimals Pet Antibiotic Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 HealthforAnimals Main Business Overview
13.9.5 HealthforAnimals Latest Developments
13.10 Cymedica
13.10.1 Cymedica Company Information
13.10.2 Cymedica Pet Antibiotic Product Offered
13.10.3 Cymedica Pet Antibiotic Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 Cymedica Main Business Overview
13.10.5 Cymedica Latest Developments
13.11 Dechra
13.11.1 Dechra Company Information
13.11.2 Dechra Pet Antibiotic Product Offered
13.11.3 Dechra Pet Antibiotic Sales, Revenue, Price and Gross Margin (2020-2022)
13.11.4 Dechra Main Business Overview
13.11.5 Dechra Latest Developments
13.12 Jinhe Biotechnology
13.12.1 Jinhe Biotechnology Company Information
13.12.2 Jinhe Biotechnology Pet Antibiotic Product Offered
13.12.3 Jinhe Biotechnology Pet Antibiotic Sales, Revenue, Price and Gross Margin (2020-2022)
13.12.4 Jinhe Biotechnology Main Business Overview
13.12.5 Jinhe Biotechnology Latest Developments
13.13 Orion Corporation
13.13.1 Orion Corporation Company Information
13.13.2 Orion Corporation Pet Antibiotic Product Offered
13.13.3 Orion Corporation Pet Antibiotic Sales, Revenue, Price and Gross Margin (2020-2022)
13.13.4 Orion Corporation Main Business Overview
13.13.5 Orion Corporation Latest Developments
13.14 Phibro Animal Health Corporation
13.14.1 Phibro Animal Health Corporation Company Information
13.14.2 Phibro Animal Health Corporation Pet Antibiotic Product Offered
13.14.3 Phibro Animal Health Corporation Pet Antibiotic Sales, Revenue, Price and Gross Margin (2020-2022)
13.14.4 Phibro Animal Health Corporation Main Business Overview
13.14.5 Phibro Animal Health Corporation Latest Developments
13.15 Vetoquinol
13.15.1 Vetoquinol Company Information
13.15.2 Vetoquinol Pet Antibiotic Product Offered
13.15.3 Vetoquinol Pet Antibiotic Sales, Revenue, Price and Gross Margin (2020-2022)
13.15.4 Vetoquinol Main Business Overview
13.15.5 Vetoquinol Latest Developments
13.16 Virbac
13.16.1 Virbac Company Information
13.16.2 Virbac Pet Antibiotic Product Offered
13.16.3 Virbac Pet Antibiotic Sales, Revenue, Price and Gross Margin (2020-2022)
13.16.4 Virbac Main Business Overview
13.16.5 Virbac Latest Developments
13.17 Zydus
13.17.1 Zydus Company Information
13.17.2 Zydus Pet Antibiotic Product Offered
13.17.3 Zydus Pet Antibiotic Sales, Revenue, Price and Gross Margin (2020-2022)
13.17.4 Zydus Main Business Overview
13.17.5 Zydus Latest Developments
14 Research Findings and Conclusion
Tables and Figures
List of Tables
Table 1. Pet Antibiotic Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Pet Antibiotic Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Oral
Table 4. Major Players of Injection
Table 5. Major Players of Others
Table 6. Global Pet Antibiotic Sales by Type (2017-2022) & (K Units)
Table 7. Global Pet Antibiotic Sales Market Share by Type (2017-2022)
Table 8. Global Pet Antibiotic Revenue by Type (2017-2022) & ($ million)
Table 9. Global Pet Antibiotic Revenue Market Share by Type (2017-2022)
Table 10. Global Pet Antibiotic Sale Price by Type (2017-2022) & (US$/Unit)
Table 11. Global Pet Antibiotic Sales by Application (2017-2022) & (K Units)
Table 12. Global Pet Antibiotic Sales Market Share by Application (2017-2022)
Table 13. Global Pet Antibiotic Revenue by Application (2017-2022)
Table 14. Global Pet Antibiotic Revenue Market Share by Application (2017-2022)
Table 15. Global Pet Antibiotic Sale Price by Application (2017-2022) & (US$/Unit)
Table 16. Global Pet Antibiotic Sales by Company (2020-2022) & (K Units)
Table 17. Global Pet Antibiotic Sales Market Share by Company (2020-2022)
Table 18. Global Pet Antibiotic Revenue by Company (2020-2022) ($ Millions)
Table 19. Global Pet Antibiotic Revenue Market Share by Company (2020-2022)
Table 20. Global Pet Antibiotic Sale Price by Company (2020-2022) & (US$/Unit)
Table 21. Key Manufacturers Pet Antibiotic Producing Area Distribution and Sales Area
Table 22. Players Pet Antibiotic Products Offered
Table 23. Pet Antibiotic Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Pet Antibiotic Sales by Geographic Region (2017-2022) & (K Units)
Table 27. Global Pet Antibiotic Sales Market Share Geographic Region (2017-2022)
Table 28. Global Pet Antibiotic Revenue by Geographic Region (2017-2022) & ($ millions)
Table 29. Global Pet Antibiotic Revenue Market Share by Geographic Region (2017-2022)
Table 30. Global Pet Antibiotic Sales by Country/Region (2017-2022) & (K Units)
Table 31. Global Pet Antibiotic Sales Market Share by Country/Region (2017-2022)
Table 32. Global Pet Antibiotic Revenue by Country/Region (2017-2022) & ($ millions)
Table 33. Global Pet Antibiotic Revenue Market Share by Country/Region (2017-2022)
Table 34. Americas Pet Antibiotic Sales by Country (2017-2022) & (K Units)
Table 35. Americas Pet Antibiotic Sales Market Share by Country (2017-2022)
Table 36. Americas Pet Antibiotic Revenue by Country (2017-2022) & ($ Millions)
Table 37. Americas Pet Antibiotic Revenue Market Share by Country (2017-2022)
Table 38. Americas Pet Antibiotic Sales by Type (2017-2022) & (K Units)
Table 39. Americas Pet Antibiotic Sales Market Share by Type (2017-2022)
Table 40. Americas Pet Antibiotic Sales by Application (2017-2022) & (K Units)
Table 41. Americas Pet Antibiotic Sales Market Share by Application (2017-2022)
Table 42. APAC Pet Antibiotic Sales by Region (2017-2022) & (K Units)
Table 43. APAC Pet Antibiotic Sales Market Share by Region (2017-2022)
Table 44. APAC Pet Antibiotic Revenue by Region (2017-2022) & ($ Millions)
Table 45. APAC Pet Antibiotic Revenue Market Share by Region (2017-2022)
Table 46. APAC Pet Antibiotic Sales by Type (2017-2022) & (K Units)
Table 47. APAC Pet Antibiotic Sales Market Share by Type (2017-2022)
Table 48. APAC Pet Antibiotic Sales by Application (2017-2022) & (K Units)
Table 49. APAC Pet Antibiotic Sales Market Share by Application (2017-2022)
Table 50. Europe Pet Antibiotic Sales by Country (2017-2022) & (K Units)
Table 51. Europe Pet Antibiotic Sales Market Share by Country (2017-2022)
Table 52. Europe Pet Antibiotic Revenue by Country (2017-2022) & ($ Millions)
Table 53. Europe Pet Antibiotic Revenue Market Share by Country (2017-2022)
Table 54. Europe Pet Antibiotic Sales by Type (2017-2022) & (K Units)
Table 55. Europe Pet Antibiotic Sales Market Share by Type (2017-2022)
Table 56. Europe Pet Antibiotic Sales by Application (2017-2022) & (K Units)
Table 57. Europe Pet Antibiotic Sales Market Share by Application (2017-2022)
Table 58. Middle East & Africa Pet Antibiotic Sales by Country (2017-2022) & (K Units)
Table 59. Middle East & Africa Pet Antibiotic Sales Market Share by Country (2017-2022)
Table 60. Middle East & Africa Pet Antibiotic Revenue by Country (2017-2022) & ($ Millions)
Table 61. Middle East & Africa Pet Antibiotic Revenue Market Share by Country (2017-2022)
Table 62. Middle East & Africa Pet Antibiotic Sales by Type (2017-2022) & (K Units)
Table 63. Middle East & Africa Pet Antibiotic Sales Market Share by Type (2017-2022)
Table 64. Middle East & Africa Pet Antibiotic Sales by Application (2017-2022) & (K Units)
Table 65. Middle East & Africa Pet Antibiotic Sales Market Share by Application (2017-2022)
Table 66. Key Market Drivers & Growth Opportunities of Pet Antibiotic
Table 67. Key Market Challenges & Risks of Pet Antibiotic
Table 68. Key Industry Trends of Pet Antibiotic
Table 69. Pet Antibiotic Raw Material
Table 70. Key Suppliers of Raw Materials
Table 71. Pet Antibiotic Distributors List
Table 72. Pet Antibiotic Customer List
Table 73. Global Pet Antibiotic Sales Forecast by Region (2023-2028) & (K Units)
Table 74. Global Pet Antibiotic Sales Market Forecast by Region
Table 75. Global Pet Antibiotic Revenue Forecast by Region (2023-2028) & ($ millions)
Table 76. Global Pet Antibiotic Revenue Market Share Forecast by Region (2023-2028)
Table 77. Americas Pet Antibiotic Sales Forecast by Country (2023-2028) & (K Units)
Table 78. Americas Pet Antibiotic Revenue Forecast by Country (2023-2028) & ($ millions)
Table 79. APAC Pet Antibiotic Sales Forecast by Region (2023-2028) & (K Units)
Table 80. APAC Pet Antibiotic Revenue Forecast by Region (2023-2028) & ($ millions)
Table 81. Europe Pet Antibiotic Sales Forecast by Country (2023-2028) & (K Units)
Table 82. Europe Pet Antibiotic Revenue Forecast by Country (2023-2028) & ($ millions)
Table 83. Middle East & Africa Pet Antibiotic Sales Forecast by Country (2023-2028) & (K Units)
Table 84. Middle East & Africa Pet Antibiotic Revenue Forecast by Country (2023-2028) & ($ millions)
Table 85. Global Pet Antibiotic Sales Forecast by Type (2023-2028) & (K Units)
Table 86. Global Pet Antibiotic Sales Market Share Forecast by Type (2023-2028)
Table 87. Global Pet Antibiotic Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 88. Global Pet Antibiotic Revenue Market Share Forecast by Type (2023-2028)
Table 89. Global Pet Antibiotic Sales Forecast by Application (2023-2028) & (K Units)
Table 90. Global Pet Antibiotic Sales Market Share Forecast by Application (2023-2028)
Table 91. Global Pet Antibiotic Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 92. Global Pet Antibiotic Revenue Market Share Forecast by Application (2023-2028)
Table 93. Elanco Basic Information, Pet Antibiotic Manufacturing Base, Sales Area and Its Competitors
Table 94. Elanco Pet Antibiotic Product Offered
Table 95. Elanco Pet Antibiotic Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 96. Elanco Main Business
Table 97. Elanco Latest Developments
Table 98. Zoetis Basic Information, Pet Antibiotic Manufacturing Base, Sales Area and Its Competitors
Table 99. Zoetis Pet Antibiotic Product Offered
Table 100. Zoetis Pet Antibiotic Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 101. Zoetis Main Business
Table 102. Zoetis Latest Developments
Table 103. Merck Animal Health Basic Information, Pet Antibiotic Manufacturing Base, Sales Area and Its Competitors
Table 104. Merck Animal Health Pet Antibiotic Product Offered
Table 105. Merck Animal Health Pet Antibiotic Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 106. Merck Animal Health Main Business
Table 107. Merck Animal Health Latest Developments
Table 108. Merial Basic Information, Pet Antibiotic Manufacturing Base, Sales Area and Its Competitors
Table 109. Merial Pet Antibiotic Product Offered
Table 110. Merial Pet Antibiotic Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 111. Merial Main Business
Table 112. Merial Latest Developments
Table 113. Bayer HealthCare Basic Information, Pet Antibiotic Manufacturing Base, Sales Area and Its Competitors
Table 114. Bayer HealthCare Pet Antibiotic Product Offered
Table 115. Bayer HealthCare Pet Antibiotic Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 116. Bayer HealthCare Main Business
Table 117. Bayer HealthCare Latest Developments
Table 118. Boehringer Ingelheim GmbH Basic Information, Pet Antibiotic Manufacturing Base, Sales Area and Its Competitors
Table 119. Boehringer Ingelheim GmbH Pet Antibiotic Product Offered
Table 120. Boehringer Ingelheim GmbH Pet Antibiotic Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 121. Boehringer Ingelheim GmbH Main Business
Table 122. Boehringer Ingelheim GmbH Latest Developments
Table 123. Ceva Santé Animale Basic Information, Pet Antibiotic Manufacturing Base, Sales Area and Its Competitors
Table 124. Ceva Santé Animale Pet Antibiotic Product Offered
Table 125. Ceva Santé Animale Pet Antibiotic Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 126. Ceva Santé Animale Main Business
Table 127. Ceva Santé Animale Latest Developments
Table 128. Virbac Group Basic Information, Pet Antibiotic Manufacturing Base, Sales Area and Its Competitors
Table 129. Virbac Group Pet Antibiotic Product Offered
Table 130. Virbac Group Pet Antibiotic Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 131. Virbac Group Main Business
Table 132. Virbac Group Latest Developments
Table 133. HealthforAnimals Basic Information, Pet Antibiotic Manufacturing Base, Sales Area and Its Competitors
Table 134. HealthforAnimals Pet Antibiotic Product Offered
Table 135. HealthforAnimals Pet Antibiotic Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 136. HealthforAnimals Main Business
Table 137. HealthforAnimals Latest Developments
Table 138. Cymedica Basic Information, Pet Antibiotic Manufacturing Base, Sales Area and Its Competitors
Table 139. Cymedica Pet Antibiotic Product Offered
Table 140. Cymedica Pet Antibiotic Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 141. Cymedica Main Business
Table 142. Cymedica Latest Developments
Table 143. Dechra Basic Information, Pet Antibiotic Manufacturing Base, Sales Area and Its Competitors
Table 144. Dechra Pet Antibiotic Product Offered
Table 145. Dechra Pet Antibiotic Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 146. Dechra Main Business
Table 147. Dechra Latest Developments
Table 148. Jinhe Biotechnology Basic Information, Pet Antibiotic Manufacturing Base, Sales Area and Its Competitors
Table 149. Jinhe Biotechnology Pet Antibiotic Product Offered
Table 150. Jinhe Biotechnology Pet Antibiotic Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 151. Jinhe Biotechnology Main Business
Table 152. Jinhe Biotechnology Latest Developments
Table 153. Orion Corporation Basic Information, Pet Antibiotic Manufacturing Base, Sales Area and Its Competitors
Table 154. Orion Corporation Pet Antibiotic Product Offered
Table 155. Orion Corporation Pet Antibiotic Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 156. Orion Corporation Main Business
Table 157. Orion Corporation Latest Developments
Table 158. Phibro Animal Health Corporation Basic Information, Pet Antibiotic Manufacturing Base, Sales Area and Its Competitors
Table 159. Phibro Animal Health Corporation Pet Antibiotic Product Offered
Table 160. Phibro Animal Health Corporation Pet Antibiotic Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 161. Phibro Animal Health Corporation Main Business
Table 162. Phibro Animal Health Corporation Latest Developments
Table 163. Vetoquinol Basic Information, Pet Antibiotic Manufacturing Base, Sales Area and Its Competitors
Table 164. Vetoquinol Pet Antibiotic Product Offered
Table 165. Vetoquinol Pet Antibiotic Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 166. Vetoquinol Main Business
Table 167. Vetoquinol Latest Developments
Table 168. Virbac Basic Information, Pet Antibiotic Manufacturing Base, Sales Area and Its Competitors
Table 169. Virbac Pet Antibiotic Product Offered
Table 170. Virbac Pet Antibiotic Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 171. Virbac Main Business
Table 172. Virbac Latest Developments
Table 173. Zydus Basic Information, Pet Antibiotic Manufacturing Base, Sales Area and Its Competitors
Table 174. Zydus Pet Antibiotic Product Offered
Table 175. Zydus Pet Antibiotic Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 176. Zydus Main Business
Table 177. Zydus Latest Developments
List of Figures
Figure 1. Picture of Pet Antibiotic
Figure 2. Pet Antibiotic Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Pet Antibiotic Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global Pet Antibiotic Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Pet Antibiotic Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Oral
Figure 10. Product Picture of Injection
Figure 11. Product Picture of Others
Figure 12. Global Pet Antibiotic Sales Market Share by Type in 2021
Figure 13. Global Pet Antibiotic Revenue Market Share by Type (2017-2022)
Figure 14. Pet Antibiotic Consumed in Dogs
Figure 15. Global Pet Antibiotic Market: Dogs (2017-2022) & (K Units)
Figure 16. Pet Antibiotic Consumed in Cats
Figure 17. Global Pet Antibiotic Market: Cats (2017-2022) & (K Units)
Figure 18. Pet Antibiotic Consumed in Others
Figure 19. Global Pet Antibiotic Market: Others (2017-2022) & (K Units)
Figure 20. Global Pet Antibiotic Sales Market Share by Application (2017-2022)
Figure 21. Global Pet Antibiotic Revenue Market Share by Application in 2021
Figure 22. Pet Antibiotic Revenue Market by Company in 2021 ($ Million)
Figure 23. Global Pet Antibiotic Revenue Market Share by Company in 2021
Figure 24. Global Pet Antibiotic Sales Market Share by Geographic Region (2017-2022)
Figure 25. Global Pet Antibiotic Revenue Market Share by Geographic Region in 2021
Figure 26. Global Pet Antibiotic Sales Market Share by Region (2017-2022)
Figure 27. Global Pet Antibiotic Revenue Market Share by Country/Region in 2021
Figure 28. Americas Pet Antibiotic Sales 2017-2022 (K Units)
Figure 29. Americas Pet Antibiotic Revenue 2017-2022 ($ Millions)
Figure 30. APAC Pet Antibiotic Sales 2017-2022 (K Units)
Figure 31. APAC Pet Antibiotic Revenue 2017-2022 ($ Millions)
Figure 32. Europe Pet Antibiotic Sales 2017-2022 (K Units)
Figure 33. Europe Pet Antibiotic Revenue 2017-2022 ($ Millions)
Figure 34. Middle East & Africa Pet Antibiotic Sales 2017-2022 (K Units)
Figure 35. Middle East & Africa Pet Antibiotic Revenue 2017-2022 ($ Millions)
Figure 36. Americas Pet Antibiotic Sales Market Share by Country in 2021
Figure 37. Americas Pet Antibiotic Revenue Market Share by Country in 2021
Figure 38. United States Pet Antibiotic Revenue Growth 2017-2022 ($ Millions)
Figure 39. Canada Pet Antibiotic Revenue Growth 2017-2022 ($ Millions)
Figure 40. Mexico Pet Antibiotic Revenue Growth 2017-2022 ($ Millions)
Figure 41. Brazil Pet Antibiotic Revenue Growth 2017-2022 ($ Millions)
Figure 42. APAC Pet Antibiotic Sales Market Share by Region in 2021
Figure 43. APAC Pet Antibiotic Revenue Market Share by Regions in 2021
Figure 44. China Pet Antibiotic Revenue Growth 2017-2022 ($ Millions)
Figure 45. Japan Pet Antibiotic Revenue Growth 2017-2022 ($ Millions)
Figure 46. South Korea Pet Antibiotic Revenue Growth 2017-2022 ($ Millions)
Figure 47. Southeast Asia Pet Antibiotic Revenue Growth 2017-2022 ($ Millions)
Figure 48. India Pet Antibiotic Revenue Growth 2017-2022 ($ Millions)
Figure 49. Australia Pet Antibiotic Revenue Growth 2017-2022 ($ Millions)
Figure 50. Europe Pet Antibiotic Sales Market Share by Country in 2021
Figure 51. Europe Pet Antibiotic Revenue Market Share by Country in 2021
Figure 52. Germany Pet Antibiotic Revenue Growth 2017-2022 ($ Millions)
Figure 53. France Pet Antibiotic Revenue Growth 2017-2022 ($ Millions)
Figure 54. UK Pet Antibiotic Revenue Growth 2017-2022 ($ Millions)
Figure 55. Italy Pet Antibiotic Revenue Growth 2017-2022 ($ Millions)
Figure 56. Russia Pet Antibiotic Revenue Growth 2017-2022 ($ Millions)
Figure 57. Middle East & Africa Pet Antibiotic Sales Market Share by Country in 2021
Figure 58. Middle East & Africa Pet Antibiotic Revenue Market Share by Country in 2021
Figure 59. Egypt Pet Antibiotic Revenue Growth 2017-2022 ($ Millions)
Figure 60. South Africa Pet Antibiotic Revenue Growth 2017-2022 ($ Millions)
Figure 61. Israel Pet Antibiotic Revenue Growth 2017-2022 ($ Millions)
Figure 62. Turkey Pet Antibiotic Revenue Growth 2017-2022 ($ Millions)
Figure 63. GCC Country Pet Antibiotic Revenue Growth 2017-2022 ($ Millions)
Figure 64. Manufacturing Cost Structure Analysis of Pet Antibiotic in 2021
Figure 65. Manufacturing Process Analysis of Pet Antibiotic
Figure 66. Industry Chain Structure of Pet Antibiotic
Figure 67. Channels of Distribution
Figure 68. Distributors Profiles
Reason to Buy
- Current and future of Pharma & Healthcare Market outlook in the developed and emerging markets
- Highlights key business priorities in order to assist companies to realign their business strategies
- The segment that is expected to dominate the Pharma & Healthcare Market
- Regions that are expected to witness the fastest growth during the forecast period
- Identify the latest developments, Pharma & Healthcare Market shares, and strategies employed by the major market players
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Pharma & Healthcare Market
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets